COVID-19 Impact on Global Bone Cancer Drugs Market Size, Status and Forecast 2020-2026

July 2020 | 98 pages | ID: CD2E3671C036EN
QYResearch

Abstracts

This report focuses on the global Bone Cancer Drugs status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Bone Cancer Drugs development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study

• Pfizer
• Bayer
• Novartis
• Amgen
• Merck
• Takeda Pharmaceutical
• Johnson?Johnson
• Bristol-Myers Squibb

Market segment by Type, the product can be split into

• Chemotherapy
• Targeted Therapy

Market segment by Application, split into

• Primary Bone Cancer
• Secondary Bone Cancer

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Bone Cancer Drugs status, future forecast, growth opportunity, key market and key players.
• To present the Bone Cancer Drugs development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Bone Cancer Drugs are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Bone Cancer Drugs Revenue
1.4 Market Analysis by Type
  1.4.1 Global Bone Cancer Drugs Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Chemotherapy
  1.4.3 Targeted Therapy
1.5 Market by Application
  1.5.1 Global Bone Cancer Drugs Market Share by Application: 2020 VS 2026
  1.5.2 Primary Bone Cancer
  1.5.3 Secondary Bone Cancer
1.6 Coronavirus Disease 2019 (Covid-19): Bone Cancer Drugs Industry Impact
  1.6.1 How the Covid-19 is Affecting the Bone Cancer Drugs Industry
    1.6.1.1 Bone Cancer Drugs Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Bone Cancer Drugs Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Bone Cancer Drugs Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Bone Cancer Drugs Market Perspective (2015-2026)
2.2 Bone Cancer Drugs Growth Trends by Regions
  2.2.1 Bone Cancer Drugs Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Bone Cancer Drugs Historic Market Share by Regions (2015-2020)
  2.2.3 Bone Cancer Drugs Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Bone Cancer Drugs Market Growth Strategy
  2.3.6 Primary Interviews with Key Bone Cancer Drugs Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Bone Cancer Drugs Players by Market Size
  3.1.1 Global Top Bone Cancer Drugs Players by Revenue (2015-2020)
  3.1.2 Global Bone Cancer Drugs Revenue Market Share by Players (2015-2020)
  3.1.3 Global Bone Cancer Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Bone Cancer Drugs Market Concentration Ratio
  3.2.1 Global Bone Cancer Drugs Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Bone Cancer Drugs Revenue in 2019
3.3 Bone Cancer Drugs Key Players Head office and Area Served
3.4 Key Players Bone Cancer Drugs Product Solution and Service
3.5 Date of Enter into Bone Cancer Drugs Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Bone Cancer Drugs Historic Market Size by Type (2015-2020)
4.2 Global Bone Cancer Drugs Forecasted Market Size by Type (2021-2026)

5 BONE CANCER DRUGS BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Bone Cancer Drugs Market Size by Application (2015-2020)
5.2 Global Bone Cancer Drugs Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Bone Cancer Drugs Market Size (2015-2020)
6.2 Bone Cancer Drugs Key Players in North America (2019-2020)
6.3 North America Bone Cancer Drugs Market Size by Type (2015-2020)
6.4 North America Bone Cancer Drugs Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Bone Cancer Drugs Market Size (2015-2020)
7.2 Bone Cancer Drugs Key Players in Europe (2019-2020)
7.3 Europe Bone Cancer Drugs Market Size by Type (2015-2020)
7.4 Europe Bone Cancer Drugs Market Size by Application (2015-2020)

8 CHINA

8.1 China Bone Cancer Drugs Market Size (2015-2020)
8.2 Bone Cancer Drugs Key Players in China (2019-2020)
8.3 China Bone Cancer Drugs Market Size by Type (2015-2020)
8.4 China Bone Cancer Drugs Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Bone Cancer Drugs Market Size (2015-2020)
9.2 Bone Cancer Drugs Key Players in Japan (2019-2020)
9.3 Japan Bone Cancer Drugs Market Size by Type (2015-2020)
9.4 Japan Bone Cancer Drugs Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Bone Cancer Drugs Market Size (2015-2020)
10.2 Bone Cancer Drugs Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Bone Cancer Drugs Market Size by Type (2015-2020)
10.4 Southeast Asia Bone Cancer Drugs Market Size by Application (2015-2020)

11 INDIA

11.1 India Bone Cancer Drugs Market Size (2015-2020)
11.2 Bone Cancer Drugs Key Players in India (2019-2020)
11.3 India Bone Cancer Drugs Market Size by Type (2015-2020)
11.4 India Bone Cancer Drugs Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Bone Cancer Drugs Market Size (2015-2020)
12.2 Bone Cancer Drugs Key Players in Central & South America (2019-2020)
12.3 Central & South America Bone Cancer Drugs Market Size by Type (2015-2020)
12.4 Central & South America Bone Cancer Drugs Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 Pfizer
  13.1.1 Pfizer Company Details
  13.1.2 Pfizer Business Overview and Its Total Revenue
  13.1.3 Pfizer Bone Cancer Drugs Introduction
  13.1.4 Pfizer Revenue in Bone Cancer Drugs Business (2015-2020))
  13.1.5 Pfizer Recent Development
13.2 Bayer
  13.2.1 Bayer Company Details
  13.2.2 Bayer Business Overview and Its Total Revenue
  13.2.3 Bayer Bone Cancer Drugs Introduction
  13.2.4 Bayer Revenue in Bone Cancer Drugs Business (2015-2020)
  13.2.5 Bayer Recent Development
13.3 Novartis
  13.3.1 Novartis Company Details
  13.3.2 Novartis Business Overview and Its Total Revenue
  13.3.3 Novartis Bone Cancer Drugs Introduction
  13.3.4 Novartis Revenue in Bone Cancer Drugs Business (2015-2020)
  13.3.5 Novartis Recent Development
13.4 Amgen
  13.4.1 Amgen Company Details
  13.4.2 Amgen Business Overview and Its Total Revenue
  13.4.3 Amgen Bone Cancer Drugs Introduction
  13.4.4 Amgen Revenue in Bone Cancer Drugs Business (2015-2020)
  13.4.5 Amgen Recent Development
13.5 Merck
  13.5.1 Merck Company Details
  13.5.2 Merck Business Overview and Its Total Revenue
  13.5.3 Merck Bone Cancer Drugs Introduction
  13.5.4 Merck Revenue in Bone Cancer Drugs Business (2015-2020)
  13.5.5 Merck Recent Development
13.6 Takeda Pharmaceutical
  13.6.1 Takeda Pharmaceutical Company Details
  13.6.2 Takeda Pharmaceutical Business Overview and Its Total Revenue
  13.6.3 Takeda Pharmaceutical Bone Cancer Drugs Introduction
  13.6.4 Takeda Pharmaceutical Revenue in Bone Cancer Drugs Business (2015-2020)
  13.6.5 Takeda Pharmaceutical Recent Development
13.7 Johnson?Johnson
  13.7.1 Johnson?Johnson Company Details
  13.7.2 Johnson?Johnson Business Overview and Its Total Revenue
  13.7.3 Johnson?Johnson Bone Cancer Drugs Introduction
  13.7.4 Johnson?Johnson Revenue in Bone Cancer Drugs Business (2015-2020)
  13.7.5 Johnson?Johnson Recent Development
13.8 Bristol-Myers Squibb
  13.8.1 Bristol-Myers Squibb Company Details
  13.8.2 Bristol-Myers Squibb Business Overview and Its Total Revenue
  13.8.3 Bristol-Myers Squibb Bone Cancer Drugs Introduction
  13.8.4 Bristol-Myers Squibb Revenue in Bone Cancer Drugs Business (2015-2020)
  13.8.5 Bristol-Myers Squibb Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Bone Cancer Drugs Key Market Segments
Table 2. Key Players Covered: Ranking by Bone Cancer Drugs Revenue
Table 3. Ranking of Global Top Bone Cancer Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Bone Cancer Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Chemotherapy
Table 6. Key Players of Targeted Therapy
Table 7. COVID-19 Impact Global Market: (Four Bone Cancer Drugs Market Size Forecast Scenarios)
Table 8. Opportunities and Trends for Bone Cancer Drugs Players in the COVID-19 Landscape
Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 10. Key Regions/Countries Measures against Covid-19 Impact
Table 11. Proposal for Bone Cancer Drugs Players to Combat Covid-19 Impact
Table 12. Global Bone Cancer Drugs Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 13. Global Bone Cancer Drugs Market Size by Regions (US$ Million): 2020 VS 2026
Table 14. Global Bone Cancer Drugs Market Size by Regions (2015-2020) (US$ Million)
Table 15. Global Bone Cancer Drugs Market Share by Regions (2015-2020)
Table 16. Global Bone Cancer Drugs Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 17. Global Bone Cancer Drugs Market Share by Regions (2021-2026)
Table 18. Market Top Trends
Table 19. Key Drivers: Impact Analysis
Table 20. Key Challenges
Table 21. Bone Cancer Drugs Market Growth Strategy
Table 22. Main Points Interviewed from Key Bone Cancer Drugs Players
Table 23. Global Bone Cancer Drugs Revenue by Players (2015-2020) (Million US$)
Table 24. Global Bone Cancer Drugs Market Share by Players (2015-2020)
Table 25. Global Top Bone Cancer Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Bone Cancer Drugs as of 2019)
Table 26. Global Bone Cancer Drugs by Players Market Concentration Ratio (CR5 and HHI)
Table 27. Key Players Headquarters and Area Served
Table 28. Key Players Bone Cancer Drugs Product Solution and Service
Table 29. Date of Enter into Bone Cancer Drugs Market
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Bone Cancer Drugs Market Size by Type (2015-2020) (Million US$)
Table 32. Global Bone Cancer Drugs Market Size Share by Type (2015-2020)
Table 33. Global Bone Cancer Drugs Revenue Market Share by Type (2021-2026)
Table 34. Global Bone Cancer Drugs Market Size Share by Application (2015-2020)
Table 35. Global Bone Cancer Drugs Market Size by Application (2015-2020) (Million US$)
Table 36. Global Bone Cancer Drugs Market Size Share by Application (2021-2026)
Table 37. North America Key Players Bone Cancer Drugs Revenue (2019-2020) (Million US$)
Table 38. North America Key Players Bone Cancer Drugs Market Share (2019-2020)
Table 39. North America Bone Cancer Drugs Market Size by Type (2015-2020) (Million US$)
Table 40. North America Bone Cancer Drugs Market Share by Type (2015-2020)
Table 41. North America Bone Cancer Drugs Market Size by Application (2015-2020) (Million US$)
Table 42. North America Bone Cancer Drugs Market Share by Application (2015-2020)
Table 43. Europe Key Players Bone Cancer Drugs Revenue (2019-2020) (Million US$)
Table 44. Europe Key Players Bone Cancer Drugs Market Share (2019-2020)
Table 45. Europe Bone Cancer Drugs Market Size by Type (2015-2020) (Million US$)
Table 46. Europe Bone Cancer Drugs Market Share by Type (2015-2020)
Table 47. Europe Bone Cancer Drugs Market Size by Application (2015-2020) (Million US$)
Table 48. Europe Bone Cancer Drugs Market Share by Application (2015-2020)
Table 49. China Key Players Bone Cancer Drugs Revenue (2019-2020) (Million US$)
Table 50. China Key Players Bone Cancer Drugs Market Share (2019-2020)
Table 51. China Bone Cancer Drugs Market Size by Type (2015-2020) (Million US$)
Table 52. China Bone Cancer Drugs Market Share by Type (2015-2020)
Table 53. China Bone Cancer Drugs Market Size by Application (2015-2020) (Million US$)
Table 54. China Bone Cancer Drugs Market Share by Application (2015-2020)
Table 55. Japan Key Players Bone Cancer Drugs Revenue (2019-2020) (Million US$)
Table 56. Japan Key Players Bone Cancer Drugs Market Share (2019-2020)
Table 57. Japan Bone Cancer Drugs Market Size by Type (2015-2020) (Million US$)
Table 58. Japan Bone Cancer Drugs Market Share by Type (2015-2020)
Table 59. Japan Bone Cancer Drugs Market Size by Application (2015-2020) (Million US$)
Table 60. Japan Bone Cancer Drugs Market Share by Application (2015-2020)
Table 61. Southeast Asia Key Players Bone Cancer Drugs Revenue (2019-2020) (Million US$)
Table 62. Southeast Asia Key Players Bone Cancer Drugs Market Share (2019-2020)
Table 63. Southeast Asia Bone Cancer Drugs Market Size by Type (2015-2020) (Million US$)
Table 64. Southeast Asia Bone Cancer Drugs Market Share by Type (2015-2020)
Table 65. Southeast Asia Bone Cancer Drugs Market Size by Application (2015-2020) (Million US$)
Table 66. Southeast Asia Bone Cancer Drugs Market Share by Application (2015-2020)
Table 67. India Key Players Bone Cancer Drugs Revenue (2019-2020) (Million US$)
Table 68. India Key Players Bone Cancer Drugs Market Share (2019-2020)
Table 69. India Bone Cancer Drugs Market Size by Type (2015-2020) (Million US$)
Table 70. India Bone Cancer Drugs Market Share by Type (2015-2020)
Table 71. India Bone Cancer Drugs Market Size by Application (2015-2020) (Million US$)
Table 72. India Bone Cancer Drugs Market Share by Application (2015-2020)
Table 73. Central & South America Key Players Bone Cancer Drugs Revenue (2019-2020) (Million US$)
Table 74. Central & South America Key Players Bone Cancer Drugs Market Share (2019-2020)
Table 75. Central & South America Bone Cancer Drugs Market Size by Type (2015-2020) (Million US$)
Table 76. Central & South America Bone Cancer Drugs Market Share by Type (2015-2020)
Table 77. Central & South America Bone Cancer Drugs Market Size by Application (2015-2020) (Million US$)
Table 78. Central & South America Bone Cancer Drugs Market Share by Application (2015-2020)
Table 79. Pfizer Company Details
Table 80. Pfizer Business Overview
Table 81. Pfizer Product
Table 82. Pfizer Revenue in Bone Cancer Drugs Business (2015-2020) (Million US$)
Table 83. Pfizer Recent Development
Table 84. Bayer Company Details
Table 85. Bayer Business Overview
Table 86. Bayer Product
Table 87. Bayer Revenue in Bone Cancer Drugs Business (2015-2020) (Million US$)
Table 88. Bayer Recent Development
Table 89. Novartis Company Details
Table 90. Novartis Business Overview
Table 91. Novartis Product
Table 92. Novartis Revenue in Bone Cancer Drugs Business (2015-2020) (Million US$)
Table 93. Novartis Recent Development
Table 94. Amgen Company Details
Table 95. Amgen Business Overview
Table 96. Amgen Product
Table 97. Amgen Revenue in Bone Cancer Drugs Business (2015-2020) (Million US$)
Table 98. Amgen Recent Development
Table 99. Merck Company Details
Table 100. Merck Business Overview
Table 101. Merck Product
Table 102. Merck Revenue in Bone Cancer Drugs Business (2015-2020) (Million US$)
Table 103. Merck Recent Development
Table 104. Takeda Pharmaceutical Company Details
Table 105. Takeda Pharmaceutical Business Overview
Table 106. Takeda Pharmaceutical Product
Table 107. Takeda Pharmaceutical Revenue in Bone Cancer Drugs Business (2015-2020) (Million US$)
Table 108. Takeda Pharmaceutical Recent Development
Table 109. Johnson?Johnson Company Details
Table 110. Johnson?Johnson Business Overview
Table 111. Johnson?Johnson Product
Table 112. Johnson?Johnson Revenue in Bone Cancer Drugs Business (2015-2020) (Million US$)
Table 113. Johnson?Johnson Recent Development
Table 114. Bristol-Myers Squibb Business Overview
Table 115. Bristol-Myers Squibb Product
Table 116. Bristol-Myers Squibb Company Details
Table 117. Bristol-Myers Squibb Revenue in Bone Cancer Drugs Business (2015-2020) (Million US$)
Table 118. Bristol-Myers Squibb Recent Development
Table 119. Research Programs/Design for This Report
Table 120. Key Data Information from Secondary Sources
Table 121. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Bone Cancer Drugs Market Share by Type: 2020 VS 2026
Figure 2. Chemotherapy Features
Figure 3. Targeted Therapy Features
Figure 4. Global Bone Cancer Drugs Market Share by Application: 2020 VS 2026
Figure 5. Primary Bone Cancer Case Studies
Figure 6. Secondary Bone Cancer Case Studies
Figure 7. Bone Cancer Drugs Report Years Considered
Figure 8. Global Bone Cancer Drugs Market Size YoY Growth 2015-2026 (US$ Million)
Figure 9. Global Bone Cancer Drugs Market Share by Regions: 2020 VS 2026
Figure 10. Global Bone Cancer Drugs Market Share by Regions (2021-2026)
Figure 11. Porter's Five Forces Analysis
Figure 12. Global Bone Cancer Drugs Market Share by Players in 2019
Figure 13. Global Top Bone Cancer Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Bone Cancer Drugs as of 2019
Figure 14. The Top 10 and 5 Players Market Share by Bone Cancer Drugs Revenue in 2019
Figure 15. North America Bone Cancer Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 16. Europe Bone Cancer Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. China Bone Cancer Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Japan Bone Cancer Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Southeast Asia Bone Cancer Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. India Bone Cancer Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Central & South America Bone Cancer Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 23. Pfizer Revenue Growth Rate in Bone Cancer Drugs Business (2015-2020)
Figure 24. Bayer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 25. Bayer Revenue Growth Rate in Bone Cancer Drugs Business (2015-2020)
Figure 26. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 27. Novartis Revenue Growth Rate in Bone Cancer Drugs Business (2015-2020)
Figure 28. Amgen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. Amgen Revenue Growth Rate in Bone Cancer Drugs Business (2015-2020)
Figure 30. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. Merck Revenue Growth Rate in Bone Cancer Drugs Business (2015-2020)
Figure 32. Takeda Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. Takeda Pharmaceutical Revenue Growth Rate in Bone Cancer Drugs Business (2015-2020)
Figure 34. Johnson?Johnson Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. Johnson?Johnson Revenue Growth Rate in Bone Cancer Drugs Business (2015-2020)
Figure 36. Bristol-Myers Squibb Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. Bristol-Myers Squibb Revenue Growth Rate in Bone Cancer Drugs Business (2015-2020)
Figure 38. Bottom-up and Top-down Approaches for This Report
Figure 39. Data Triangulation
Figure 40. Key Executives Interviewed